InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
40%
T+90 mean return
-0.9%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Wolf Myles, Director. Director active across 1 company, notably Akebia Therapeutics, Inc.. Cumulatively, 6 reports have been logged. History available since 2 June 2021. The latest transaction was filed on 6 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
35,700 sharesCommon StockSEC:0001808317-26-000001:0
30,000 shares0Common StockSEC:0001562180-24-004910:0
30,000 shares0Common StockSEC:0001562180-23-004957:0
13,700 shares0Common StockSEC:0001562180-22-004978:0
13,700 shares0Common StockSEC:0001562180-21-004031:0
13,700 shares0Common StockSEC:0001562180-21-004031
6 of 6 declarations
About Wolf Myles
Myles Wolf is a Board Member at Akebia Therapeutics, Inc. He contributes to the governance of the company by participating in strategic decisions and providing his expertise to the board.
